GlassScriptPhysician profile
Michael S Benninger
NPI 1053487421
$32,087.08
in general payments reported to CMS, 2019-2025
16 companies · $3,073 in 2025
The $3,073 reported for 2025 was more than what 94% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,928 · 2020: $5,186 · 2021: $11K · 2022: $1,777 · 2023: $415 · 2024: $5,382 · 2025: $3,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,650 · Consulting Fee: $1,725 · Food and Beverage: $1,159 · Travel and Lodging: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,650.00 |
| Consulting Fee | $1,725.00 |
| Food and Beverage | $1,158.66 |
| Travel and Lodging | $336.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $11,481.98 | 2019-2025 | Immunocap |
| Shionogi INC | $10,833.66 | 2019-2021 | |
| Smith+Nephew, INC. | $4,152.82 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $2,685.00 | 2021 | |
| Precigen, INC. | $1,725.00 | 2025 | |
| Kerecis Limited | $170.40 | 2022 | |
| Medtronic, INC. | $162.91 | 2023-2024 | Bizact, Shiley |
| Depuy Synthes Sales INC. | $136.69 | 2025 | Synthecel, Na, Trumatch |
| Avita Medical Americas, LLC | $135.97 | 2024 | |
| Baxter Healthcare | $121.94 | 2023 | Tisseel |
| Amgen INC. | $117.06 | 2023-2025 | Tezspire, Tavneos |
| Genzyme Corporation | $102.40 | 2025 | |
| Checkpoint Surgical, INC | $94.05 | 2021 | |
| Coopersurgical, INC. | $64.18 | 2025 | Lone Star Retraction System |
| Acclarent, INC | $59.82 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $43.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Benninger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.